Differentiation of NCC from iPSC
The differentiation of NCCs from iPS (IMR90) cells was performed by dual SMAD inhibition instead of the MS5-induction step, following exactly our recently published protocol (Mica et al., 2013; Chambers et al., 2016) . At day 11 of differentiation, cells were re-plated on poly-L-ornithine/fibronectin/laminin coated dishes and expanded and cryopreserved exactly as the hESC-derived NCC. Alternatively, iPSC were generated from the human fibroblast line GM02036. Sendai virus was used as non-integrating vector to introduce the Yamanaka factors (Invitrogen) as described earlier (Choi et al., 2014) . In these iPS (GM02036) cells, the silencing of ectopic genes (Yamanaka factors) was confirmed by PCR. Pluripotency was confirmed by measurement of protein expression of Nanog, Oct4, and SSEA3/4 at passage 12. Differentiation of NCCs from iPS (GM02036) cells was performed using the rosette induction protocol with a small modification: instead of N2S medium, Neurobasal medium supplemented with N2, B27 without vitamin A (both from Gibco), L-glutamine and EGF/FGF2 was used. The same medium composition was used for the cMINC assay using these cells.
Time-lapse video microscopy to assess cell proliferation and cell tracking
The time-lapse experiment was performed using an Axio Observer.Z1 microscope (Zeiss), equipped with an Axiocam MRm camera and a live-cell chamber (equilibrated at 37°C and 9% CO 2 ). Phase contrast images of the migration zone were acquired every 10 min using a 5x objective. Afterwards, cells were stained with calcein-AM and H-33342 and migration as well as viability were quantified exactly as described in "NCC migration setup" (manuscript main part) to ensure that the toxicants worked as under standard cMINC conditions with exposure in a standard incubator.
To assess cell proliferation in the migration zone, a circle of radius 1 mm was drawn manually by an experienced person on the time-lapse images to define the ROI. Cell divisions in this ROI were manually counted, supported by a Fiji (Schindelin et al., 2012) script provided by Martin Stöckl (Bioimaging Center of the University of Konstanz (BIC)). The experimenter was blind to the respective treatments. The number of counted cell divisions was normalized to the number of migrated cells in the same well as measured with the H-33342 and calcein staining. The time-lapse experiment was performed once with three technical replicates for untreated, CytoD and FBS and with two technical replicates for taxol, LiCl, CdCl 2 and AraC.
For cell tracking experiments, cell tracking was performed manually using the ImageJ plugin "Manual Tracking". For each biological replicate, ten individual cells were traced per condition (and 20-30 cells for the untreated control). The cumulated distance of each cell was normalized to the median of the untreated control. Statistical significance was calculated on the combined data of three biological replicates using a Wilcoxon rank sum test to compare treatments to the untreated control. Fig. S1 : Characterization of H9-derived NCCs (A) Graphical representation of the differentiation procedure to obtain NCCs from human pluripotent stem cells. In a first step, cells were differentiated on MS-5 feeder cells for 20 days to a rosette stage. The rosettes were picked and differentiated further for seven days (day 0'-7'). Then, the target population was obtained by FACS sorting (HNK-1 + /Dllcells), and was further expanded for up to 30 days before freezing (days 0''-30''). (B) The expression of the NCC marker HNK-1 was monitored by FACS analysis during the expansion phase (days 7''-21''); similar data were also obtained after thawing of a frozen sample. (C) Representative 2D expression plot obtained by FACS analysis of cells after thawing: about 95% of all cells expressed either of the two NCC markers HNK-1/p75; 70-80% of the cells were double-positive. (D) NCCs were thawed and seeded under standard assay conditions. After 24 h, cells were fixed and stained for GFAP (left) and Pax6 (right). The scale bar corresponds to 100 µm. Note that in the two images no positive cells are shown, as they were usually not evident under our culture conditions. Both antibodies were used in parallel on central neural precursor cells (Pax6) and astrocytes (GFAP), and they worked well under our staining conditions.
Fig. S2: Differentiation of iPSC into NCCs and use in the cMINC assay (A)
To obtain NCCs, iPS (IMR90) cells were differentiated via dual SMAD inhibition for 11 days towards Sox10 positive NCCs as described in Mica et al. (2013) and further expanded for two weeks in N2-S medium supplemented with EGF and FGF2 before freezing. After thawing, cells were seeded on glass for 24 h before they were fixed and labelled with immunofluorescent antibodies against p75 and counterstained by H-33342. The scale bar corresponds to 50 µm. (B) The cMINC assay was performed using these iPS (IMR90)-derived NCCs under optimized assay conditions (24 h toxicant exposure; see also Fig. 4 ). Concentration-response curves were obtained for three exemplary compounds. All values are normalized to untreated controls. Data are means ± SD from three different experiments. (C) Graphical representation of the procedure to obtain NCCs from human fibroblasts via iPSC. (D) Preliminary data of iPS (GM02036)-derived NCC under optimized cMINC assay conditions (as in B). All values are normalized to untreated controls. Data are means ± SD of 4 technical replicates from one experiment.
Fig. S3
: Initial testing of assay performance under conditions used earlier for MINC scratch assays (48 h exposure) (A) A graphical representation of the assay procedure informs on the exposure scheme and test endpoints: cells (plated at 30,000/well) were treated for 48 h with compounds, followed by measurements of viability and migration at the end of the exposure period. Concentrationresponse curves were obtained for selected compounds, and all values were normalized to untreated controls. (B) Examples for positive control compounds; (C) Endpoint-specific controls for increased migration (FBS) and for the role of cell proliferation in the assay (mitotic inhibitor: AraC); (D) Exemplary test compounds from the class of environmental toxicants (acrylamide) and drugs (LiCl). The light gray dotted line indicates the 100% y-axis value for easier reading of the diagrams. The other two dotted lines are drawn at 90% (indicating threshold for reduced viability) and at 75% (indicating threshold for reduced migration). Data are means ± SD from three different experiments. Statistical evaluations were not performed; data are intended for visual overview. Fig. S3A ) was performed, and cells in the migration zone were imaged every 10 minutes using time-lapse video microscopy. The number of cells arising from mitosis in the circular region of interest (ROI) was determined from evaluation of the video tracks. For control cells, 185 ± 17 mitoses occurred. This number was normalized to the number of cells in the ROI at the end of the assay. Under control conditions, 442 ± 35 cells migrated into the ROI (e.g., 42.7% ± 5.1% of cells in the ROI were generated by proliferation instead of migration from the outside); * p < 0.05; ** p < 0.01 (conditions with inhibited proliferation are highlighted in red).
Fig. S5: Time-lapse video microscopy for cell tracking in the new cMINC assay format
NCCs were thawed and plated at 30,000/well. After one day, silicone stoppers were removed and medium was changed. Another 24 h later, treatment with CytoD (200 nM), taxol (10 nM), FBS (4%) and AraC (1 µM) was initiated. Cell behavior was recorded for 24 h by phase contrast time-lapse video microscopy. (A) Representative still images from the video sequence are shown for selected time points. The width of one micrograph corresponds to 1 mm. The dashed line indicates the approximate position of the migration zone. Note that only the lower left quarter of the total image (and migration zone) is shown. (B) For each treatment condition, ten individual cells were traced, and for each control about 20-30 cells were traced. For each cell, the total distance of movement along its migration track was measured. All data were normalized to untreated controls in the same experiment. As the box-and-whisker plot displays data of three different experiments, each box represents the results of 30 (treatment) or 80 (controls) tracked cells. The box represents the first and third quartiles, the black line the median (number given in the black square) and the whiskers are at an interquartile range of 1.5. CytoD, cytochalasin D; FBS, fetal bovine serum; AraC, cytosine arabinoside; *** p < 0.001, n.s.: not significant.
